AJ

Abhijeet Jayant Phase

Active Director Director DIN 08654111
DIN 08654111 First appointment Dec 2019 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhijeet Jayant Phase

Data last updated:

Abhijeet Jayant Phase is a Director at Altus Good Health Private Limited (since 2019). The company operates in Non-Profit Organizations.

DIN 08654111
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 30 Dec 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Altus Good Health Private Limited U85300MH2019PTC335220
Director30 Dec 20192019Active

Board colleagues of Abhijeet Jayant Phase

Directorship timeline

Open interactive timeline →
Altus Good Health Private Limited
Premium access

Shareholding and investment profile for Abhijeet Jayant Phase

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijeet Jayant Phase

Abhijeet Jayant Phase currently holds 1 directorship: Altus Good Health Private Limited (Director, since 30 Dec 2019).

Abhijeet Jayant Phase was first appointed on 30 Dec 2019 as Director at Altus Good Health Private Limited.

The current boards of Abhijeet Jayant Phase's companies include Nootan Ramling Mali (Altus Good Health Private Limited), Rutuj Ramling Mali (Altus Good Health Private Limited), Sneha Ramling Mali (Altus Good Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available